Check out the companies making headlines in midday trading. UnitedHealth — Shares climbed more than 6%, single-handedly pushing the Dow Jones Industrial Average higher on Tuesday. UnitedHealth posted better-than-expected first-quarter revenue and reaffirmed its full-year earnings forecast of $27.50 to $28 per share excluding items. Analysts polled by FactSet forecast $27.50. Johnson & Johnson — The drugmaker slipped 2% despite beating first-quarter profit estimates and reporting in-line revenue. Johnson & Johnson adjusted its full-year sales forecast for 2024 to a range of $88 billion to $88.4 billion compared to a previous forecast of $87.8 billion to $88.6 billion. SolarEdge Technologies — Barclays maintained an underweight rating on the solar company, saying its fixed costs will weigh on profit margins, helping send the stock down 2%. However, the Wall Street bank raised its price target on SolarEdge to $61 from $50. Shares closed Monday at $60.44. Morgan Stanley — Shares climbed nearly 4% on the heels of better-than-expected first-quarter results that saw gains in the investment bank’s wealth management, trading and advisory businesses top forecasts. The firm also surpassed analysts’ earnings and revenue estimates. Tesla — The electric vehicle maker pulled back more than 2%, adding to Monday’s losses, after Tesla said it would lay off 10% of its workforce, or roughly 14,000 employees. Live Nation Entertainment — The concert promoter slumped …
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnCheck out the companies making headlines in midday trading. UnitedHealth — Shares climbed more than 6%, single-handedly pushing the Dow Jones Industrial Average higher on Tuesday. UnitedHealth posted better-than-expected first-quarter revenue and reaffirmed its full-year earnings forecast of $27.50 to $28 per share excluding items. Analysts polled by FactSet forecast $27.50. Johnson & Johnson — The drugmaker slipped 2% despite beating first-quarter profit estimates and reporting in-line revenue. Johnson & Johnson adjusted its full-year sales forecast for 2024 to a range of $88 billion to $88.4 billion compared to a previous forecast of $87.8 billion to $88.6 billion. SolarEdge Technologies — Barclays maintained an underweight rating on the solar company, saying its fixed costs will weigh on profit margins, helping send the stock down 2%. However, the Wall Street bank raised its price target on SolarEdge to $61 from $50. Shares closed Monday at $60.44. Morgan Stanley — Shares climbed nearly 4% on the heels of better-than-expected first-quarter results that saw gains in the investment bank’s wealth management, trading and advisory businesses top forecasts. The firm also surpassed analysts’ earnings and revenue estimates. Tesla — The electric vehicle maker pulled back more than 2%, adding to Monday’s losses, after Tesla said it would lay off 10% of its workforce, or roughly 14,000 employees. Live Nation Entertainment — The concert promoter slumped …nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]
